Total Funding
57
36
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
209319
AmebaGone is developing proprietary technologies uses novel biocontrol method to destroy intractable bacterial infections.
- Marcin Filutowicz: Founder, President, CSO
- Courtney Griese: Operations Manager
About the Company
AmebaGone Inc. will solve one of the 21st century’s most compelling problems -- that of growing antibiotic resistance alongside a dwindling supply of effective antimicrobial products. Antibiotic resistance is a worldwide problem that manifests itself in agriculture, medicine, and industry. And while the threat of infectious disease is
intensifying, the discovery of new antibiotics has slowed dramatically. Pharmaceutical companies have largely abandoned the discovery of new antibiotics, despite the likelihood of an impending health crisis.
